Figure 1.

Disease‐free survival (DFS) in Child B patients with hepatocellular carcinoma who underwent splenectomy and liver resection or local ablation (splenectomy group) was significantly longer than in those who underwent liver resection or local ablation only (non‐splenectomy group). The 1‐, 3‐, and 5‐year DFS rates were 83.2%, 28.0%, and 0.0% in the splenectomy group, and 65.5%, 9.7%, and 0.0% in the non‐splenectomy group, respectively (P < 0.001). [Color figure can be viewed at http://wileyonlinelibrary.com]